Global Viral Vector CDMO Market Growth (Status and Outlook) 2022-2028
The global market for Viral Vector CDMO is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Viral Vector CDMO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Viral Vector CDMO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Viral Vector CDMO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Viral Vector CDMO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Viral Vector CDMO players cover Thermo Fisher Scientific, GenScript ProBio, Hillgene, Charles River Laboratories and Ubrigene, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Viral Vector CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Viral Vector CDMO market, with both quantitative and qualitative data, to help readers understand how the Viral Vector CDMO market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Viral Vector CDMO market and forecasts the market size by Type (IIT Grade, IND Grade and Clinical Trial Grade), by Application (Biopharmaceutical Company and Academic Scientific Research Institution.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
IIT Grade
IND Grade
Clinical Trial Grade
Commercial Production Grade
Segmentation by application
Biopharmaceutical Company
Academic Scientific Research Institution
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Thermo Fisher Scientific
GenScript ProBio
Hillgene
Charles River Laboratories
Ubrigene
Obio Technology (shanghai)
Genesail Biotech (Shanghai)
WuXi ATU
Porton Advanced Solutions
Pharmaron
Asymchem Laboratories (Tianjin)
Merck
VectorBuilder
Yposkesi
Flash Therapeutics
VIVEBiotech
Miltenyi Bioindustry
Genezen
Miltenyi Biotec
Exthera
Catalent
Chapter Introduction
Chapter 1: Scope of Viral Vector CDMO, Research Methodology, etc.
Chapter 2: Executive Summary, global Viral Vector CDMO market size and CAGR, Viral Vector CDMO market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Viral Vector CDMO revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Viral Vector CDMO revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Viral Vector CDMO market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Thermo Fisher Scientific, GenScript ProBio, Hillgene, Charles River Laboratories, Ubrigene, Obio Technology (shanghai), Genesail Biotech (Shanghai), WuXi ATU and Porton Advanced Solutions, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Viral Vector CDMO Market Size 2017-2028
2.1.2 Viral Vector CDMO Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Viral Vector CDMO Segment by Type
2.2.1 IIT Grade
2.2.2 IND Grade
2.2.3 Clinical Trial Grade
2.2.4 Commercial Production Grade
2.3 Viral Vector CDMO Market Size by Type
2.3.1 Viral Vector CDMO Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Viral Vector CDMO Market Size Market Share by Type (2017-2022)
2.4 Viral Vector CDMO Segment by Application
2.4.1 Biopharmaceutical Company
2.4.2 Academic Scientific Research Institution
2.5 Viral Vector CDMO Market Size by Application
2.5.1 Viral Vector CDMO Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Viral Vector CDMO Market Size Market Share by Application (2017-2022)
3 Viral Vector CDMO Market Size by Player
3.1 Viral Vector CDMO Market Size Market Share by Players
3.1.1 Global Viral Vector CDMO Revenue by Players (2020-2022)
3.1.2 Global Viral Vector CDMO Revenue Market Share by Players (2020-2022)
3.2 Global Viral Vector CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Viral Vector CDMO by Regions
4.1 Viral Vector CDMO Market Size by Regions (2017-2022)
4.2 Americas Viral Vector CDMO Market Size Growth (2017-2022)
4.3 APAC Viral Vector CDMO Market Size Growth (2017-2022)
4.4 Europe Viral Vector CDMO Market Size Growth (2017-2022)
4.5 Middle East & Africa Viral Vector CDMO Market Size Growth (2017-2022)
5 Americas
5.1 Americas Viral Vector CDMO Market Size by Country (2017-2022)
5.2 Americas Viral Vector CDMO Market Size by Type (2017-2022)
5.3 Americas Viral Vector CDMO Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Viral Vector CDMO Market Size by Region (2017-2022)
6.2 APAC Viral Vector CDMO Market Size by Type (2017-2022)
6.3 APAC Viral Vector CDMO Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Viral Vector CDMO by Country (2017-2022)
7.2 Europe Viral Vector CDMO Market Size by Type (2017-2022)
7.3 Europe Viral Vector CDMO Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Viral Vector CDMO by Region (2017-2022)
8.2 Middle East & Africa Viral Vector CDMO Market Size by Type (2017-2022)
8.3 Middle East & Africa Viral Vector CDMO Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Viral Vector CDMO Market Forecast
10.1 Global Viral Vector CDMO Forecast by Regions (2023-2028)
10.1.1 Global Viral Vector CDMO Forecast by Regions (2023-2028)
10.1.2 Americas Viral Vector CDMO Forecast
10.1.3 APAC Viral Vector CDMO Forecast
10.1.4 Europe Viral Vector CDMO Forecast
10.1.5 Middle East & Africa Viral Vector CDMO Forecast
10.2 Americas Viral Vector CDMO Forecast by Country (2023-2028)
10.2.1 United States Viral Vector CDMO Market Forecast
10.2.2 Canada Viral Vector CDMO Market Forecast
10.2.3 Mexico Viral Vector CDMO Market Forecast
10.2.4 Brazil Viral Vector CDMO Market Forecast
10.3 APAC Viral Vector CDMO Forecast by Region (2023-2028)
10.3.1 China Viral Vector CDMO Market Forecast
10.3.2 Japan Viral Vector CDMO Market Forecast
10.3.3 Korea Viral Vector CDMO Market Forecast
10.3.4 Southeast Asia Viral Vector CDMO Market Forecast
10.3.5 India Viral Vector CDMO Market Forecast
10.3.6 Australia Viral Vector CDMO Market Forecast
10.4 Europe Viral Vector CDMO Forecast by Country (2023-2028)
10.4.1 Germany Viral Vector CDMO Market Forecast
10.4.2 France Viral Vector CDMO Market Forecast
10.4.3 UK Viral Vector CDMO Market Forecast
10.4.4 Italy Viral Vector CDMO Market Forecast
10.4.5 Russia Viral Vector CDMO Market Forecast
10.5 Middle East & Africa Viral Vector CDMO Forecast by Region (2023-2028)
10.5.1 Egypt Viral Vector CDMO Market Forecast
10.5.2 South Africa Viral Vector CDMO Market Forecast
10.5.3 Israel Viral Vector CDMO Market Forecast
10.5.4 Turkey Viral Vector CDMO Market Forecast
10.5.5 GCC Countries Viral Vector CDMO Market Forecast
10.6 Global Viral Vector CDMO Forecast by Type (2023-2028)
10.7 Global Viral Vector CDMO Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Viral Vector CDMO Product Offered
11.1.3 Thermo Fisher Scientific Viral Vector CDMO Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 GenScript ProBio
11.2.1 GenScript ProBio Company Information
11.2.2 GenScript ProBio Viral Vector CDMO Product Offered
11.2.3 GenScript ProBio Viral Vector CDMO Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 GenScript ProBio Main Business Overview
11.2.5 GenScript ProBio Latest Developments
11.3 Hillgene
11.3.1 Hillgene Company Information
11.3.2 Hillgene Viral Vector CDMO Product Offered
11.3.3 Hillgene Viral Vector CDMO Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Hillgene Main Business Overview
11.3.5 Hillgene Latest Developments
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Information
11.4.2 Charles River Laboratories Viral Vector CDMO Product Offered
11.4.3 Charles River Laboratories Viral Vector CDMO Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Charles River Laboratories Main Business Overview
11.4.5 Charles River Laboratories Latest Developments
11.5 Ubrigene
11.5.1 Ubrigene Company Information
11.5.2 Ubrigene Viral Vector CDMO Product Offered
11.5.3 Ubrigene Viral Vector CDMO Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Ubrigene Main Business Overview
11.5.5 Ubrigene Latest Developments
11.6 Obio Technology (shanghai)
11.6.1 Obio Technology (shanghai) Company Information
11.6.2 Obio Technology (shanghai) Viral Vector CDMO Product Offered
11.6.3 Obio Technology (shanghai) Viral Vector CDMO Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Obio Technology (shanghai) Main Business Overview
11.6.5 Obio Technology (shanghai) Latest Developments
11.7 Genesail Biotech (Shanghai)
11.7.1 Genesail Biotech (Shanghai) Company Information
11.7.2 Genesail Biotech (Shanghai) Viral Vector CDMO Product Offered
11.7.3 Genesail Biotech (Shanghai) Viral Vector CDMO Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Genesail Biotech (Shanghai) Main Business Overview
11.7.5 Genesail Biotech (Shanghai) Latest Developments
11.8 WuXi ATU
11.8.1 WuXi ATU Company Information
11.8.2 WuXi ATU Viral Vector CDMO Product Offered
11.8.3 WuXi ATU Viral Vector CDMO Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 WuXi ATU Main Business Overview
11.8.5 WuXi ATU Latest Developments
11.9 Porton Advanced Solutions
11.9.1 Porton Advanced Solutions Company Information
11.9.2 Porton Advanced Solutions Viral Vector CDMO Product Offered
11.9.3 Porton Advanced Solutions Viral Vector CDMO Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Porton Advanced Solutions Main Business Overview
11.9.5 Porton Advanced Solutions Latest Developments
11.10 Pharmaron
11.10.1 Pharmaron Company Information
11.10.2 Pharmaron Viral Vector CDMO Product Offered
11.10.3 Pharmaron Viral Vector CDMO Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Pharmaron Main Business Overview
11.10.5 Pharmaron Latest Developments
11.11 Asymchem Laboratories (Tianjin)
11.11.1 Asymchem Laboratories (Tianjin) Company Information
11.11.2 Asymchem Laboratories (Tianjin) Viral Vector CDMO Product Offered
11.11.3 Asymchem Laboratories (Tianjin) Viral Vector CDMO Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Asymchem Laboratories (Tianjin) Main Business Overview
11.11.5 Asymchem Laboratories (Tianjin) Latest Developments
11.12 Merck
11.12.1 Merck Company Information
11.12.2 Merck Viral Vector CDMO Product Offered
11.12.3 Merck Viral Vector CDMO Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Merck Main Business Overview
11.12.5 Merck Latest Developments
11.13 VectorBuilder
11.13.1 VectorBuilder Company Information
11.13.2 VectorBuilder Viral Vector CDMO Product Offered
11.13.3 VectorBuilder Viral Vector CDMO Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 VectorBuilder Main Business Overview
11.13.5 VectorBuilder Latest Developments
11.14 Yposkesi
11.14.1 Yposkesi Company Information
11.14.2 Yposkesi Viral Vector CDMO Product Offered
11.14.3 Yposkesi Viral Vector CDMO Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Yposkesi Main Business Overview
11.14.5 Yposkesi Latest Developments
11.15 Flash Therapeutics
11.15.1 Flash Therapeutics Company Information
11.15.2 Flash Therapeutics Viral Vector CDMO Product Offered
11.15.3 Flash Therapeutics Viral Vector CDMO Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Flash Therapeutics Main Business Overview
11.15.5 Flash Therapeutics Latest Developments
11.16 VIVEBiotech
11.16.1 VIVEBiotech Company Information
11.16.2 VIVEBiotech Viral Vector CDMO Product Offered
11.16.3 VIVEBiotech Viral Vector CDMO Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 VIVEBiotech Main Business Overview
11.16.5 VIVEBiotech Latest Developments
11.17 Miltenyi Bioindustry
11.17.1 Miltenyi Bioindustry Company Information
11.17.2 Miltenyi Bioindustry Viral Vector CDMO Product Offered
11.17.3 Miltenyi Bioindustry Viral Vector CDMO Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Miltenyi Bioindustry Main Business Overview
11.17.5 Miltenyi Bioindustry Latest Developments
11.18 Genezen
11.18.1 Genezen Company Information
11.18.2 Genezen Viral Vector CDMO Product Offered
11.18.3 Genezen Viral Vector CDMO Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Genezen Main Business Overview
11.18.5 Genezen Latest Developments
11.19 Miltenyi Biotec
11.19.1 Miltenyi Biotec Company Information
11.19.2 Miltenyi Biotec Viral Vector CDMO Product Offered
11.19.3 Miltenyi Biotec Viral Vector CDMO Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Miltenyi Biotec Main Business Overview
11.19.5 Miltenyi Biotec Latest Developments
11.20 Exthera
11.20.1 Exthera Company Information
11.20.2 Exthera Viral Vector CDMO Product Offered
11.20.3 Exthera Viral Vector CDMO Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Exthera Main Business Overview
11.20.5 Exthera Latest Developments
11.21 Catalent
11.21.1 Catalent Company Information
11.21.2 Catalent Viral Vector CDMO Product Offered
11.21.3 Catalent Viral Vector CDMO Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Catalent Main Business Overview
11.21.5 Catalent Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Viral Vector CDMO Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of IIT Grade
Table 3. Major Players of IND Grade
Table 4. Major Players of Clinical Trial Grade
Table 5. Major Players of Commercial Production Grade
Table 6. Viral Vector CDMO Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Viral Vector CDMO Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Viral Vector CDMO Market Size Market Share by Type (2017-2022)
Table 9. Viral Vector CDMO Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Viral Vector CDMO Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Viral Vector CDMO Market Size Market Share by Application (2017-2022)
Table 12. Global Viral Vector CDMO Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Viral Vector CDMO Revenue Market Share by Player (2020-2022)
Table 14. Viral Vector CDMO Key Players Head office and Products Offered
Table 15. Viral Vector CDMO Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Viral Vector CDMO Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Viral Vector CDMO Market Size Market Share by Regions (2017-2022)
Table 20. Americas Viral Vector CDMO Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Viral Vector CDMO Market Size Market Share by Country (2017-2022)
Table 22. Americas Viral Vector CDMO Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Viral Vector CDMO Market Size Market Share by Type (2017-2022)
Table 24. Americas Viral Vector CDMO Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Viral Vector CDMO Market Size Market Share by Application (2017-2022)
Table 26. APAC Viral Vector CDMO Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Viral Vector CDMO Market Size Market Share by Region (2017-2022)
Table 28. APAC Viral Vector CDMO Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Viral Vector CDMO Market Size Market Share by Type (2017-2022)
Table 30. APAC Viral Vector CDMO Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Viral Vector CDMO Market Size Market Share by Application (2017-2022)
Table 32. Europe Viral Vector CDMO Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Viral Vector CDMO Market Size Market Share by Country (2017-2022)
Table 34. Europe Viral Vector CDMO Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Viral Vector CDMO Market Size Market Share by Type (2017-2022)
Table 36. Europe Viral Vector CDMO Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Viral Vector CDMO Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Viral Vector CDMO Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Viral Vector CDMO Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Viral Vector CDMO Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Viral Vector CDMO Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Viral Vector CDMO Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Viral Vector CDMO Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Viral Vector CDMO
Table 45. Key Market Challenges & Risks of Viral Vector CDMO
Table 46. Key Industry Trends of Viral Vector CDMO
Table 47. Global Viral Vector CDMO Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Viral Vector CDMO Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Viral Vector CDMO Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Viral Vector CDMO Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Viral Vector CDMO Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Viral Vector CDMO Market Size Market Share Forecast by Application (2023-2028)
Table 53. Thermo Fisher Scientific Details, Company Type, Viral Vector CDMO Area Served and Its Competitors
Table 54. Thermo Fisher Scientific Viral Vector CDMO Product Offered
Table 55. Thermo Fisher Scientific Viral Vector CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Thermo Fisher Scientific Main Business
Table 57. Thermo Fisher Scientific Latest Developments
Table 58. GenScript ProBio Details, Company Type, Viral Vector CDMO Area Served and Its Competitors
Table 59. GenScript ProBio Viral Vector CDMO Product Offered
Table 60. GenScript ProBio Main Business
Table 61. GenScript ProBio Viral Vector CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. GenScript ProBio Latest Developments
Table 63. Hillgene Details, Company Type, Viral Vector CDMO Area Served and Its Competitors
Table 64. Hillgene Viral Vector CDMO Product Offered
Table 65. Hillgene Main Business
Table 66. Hillgene Viral Vector CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Hillgene Latest Developments
Table 68. Charles River Laboratories Details, Company Type, Viral Vector CDMO Area Served and Its Competitors
Table 69. Charles River Laboratories Viral Vector CDMO Product Offered
Table 70. Charles River Laboratories Main Business
Table 71. Charles River Laboratories Viral Vector CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Charles River Laboratories Latest Developments
Table 73. Ubrigene Details, Company Type, Viral Vector CDMO Area Served and Its Competitors
Table 74. Ubrigene Viral Vector CDMO Product Offered
Table 75. Ubrigene Main Business
Table 76. Ubrigene Viral Vector CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Ubrigene Latest Developments
Table 78. Obio Technology (shanghai) Details, Company Type, Viral Vector CDMO Area Served and Its Competitors
Table 79. Obio Technology (shanghai) Viral Vector CDMO Product Offered
Table 80. Obio Technology (shanghai) Main Business
Table 81. Obio Technology (shanghai) Viral Vector CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Obio Technology (shanghai) Latest Developments
Table 83. Genesail Biotech (Shanghai) Details, Company Type, Viral Vector CDMO Area Served and Its Competitors
Table 84. Genesail Biotech (Shanghai) Viral Vector CDMO Product Offered
Table 85. Genesail Biotech (Shanghai) Main Business
Table 86. Genesail Biotech (Shanghai) Viral Vector CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Genesail Biotech (Shanghai) Latest Developments
Table 88. WuXi ATU Details, Company Type, Viral Vector CDMO Area Served and Its Competitors
Table 89. WuXi ATU Viral Vector CDMO Product Offered
Table 90. WuXi ATU Main Business
Table 91. WuXi ATU Viral Vector CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. WuXi ATU Latest Developments
Table 93. Porton Advanced Solutions Details, Company Type, Viral Vector CDMO Area Served and Its Competitors
Table 94. Porton Advanced Solutions Viral Vector CDMO Product Offered
Table 95. Porton Advanced Solutions Main Business
Table 96. Porton Advanced Solutions Viral Vector CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Porton Advanced Solutions Latest Developments
Table 98. Pharmaron Details, Company Type, Viral Vector CDMO Area Served and Its Competitors
Table 99. Pharmaron Viral Vector CDMO Product Offered
Table 100. Pharmaron Main Business
Table 101. Pharmaron Viral Vector CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. Pharmaron Latest Developments
Table 103. Asymchem Laboratories (Tianjin) Details, Company Type, Viral Vector CDMO Area Served and Its Competitors
Table 104. Asymchem Laboratories (Tianjin) Viral Vector CDMO Product Offered
Table 105. Asymchem Laboratories (Tianjin) Viral Vector CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 106. Asymchem Laboratories (Tianjin) Main Business
Table 107. Asymchem Laboratories (Tianjin) Latest Developments
Table 108. Merck Details, Company Type, Viral Vector CDMO Area Served and Its Competitors
Table 109. Merck Viral Vector CDMO Product Offered
Table 110. Merck Main Business
Table 111. Merck Viral Vector CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 112. Merck Latest Developments
Table 113. VectorBuilder Details, Company Type, Viral Vector CDMO Area Served and Its Competitors
Table 114. VectorBuilder Viral Vector CDMO Product Offered
Table 115. VectorBuilder Main Business
Table 116. VectorBuilder Viral Vector CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 117. VectorBuilder Latest Developments
Table 118. Yposkesi Details, Company Type, Viral Vector CDMO Area Served and Its Competitors
Table 119. Yposkesi Viral Vector CDMO Product Offered
Table 120. Yposkesi Main Business
Table 121. Yposkesi Viral Vector CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 122. Yposkesi Latest Developments
Table 123. Flash Therapeutics Details, Company Type, Viral Vector CDMO Area Served and Its Competitors
Table 124. Flash Therapeutics Viral Vector CDMO Product Offered
Table 125. Flash Therapeutics Main Business
Table 126. Flash Therapeutics Viral Vector CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 127. Flash Therapeutics Latest Developments
Table 128. VIVEBiotech Details, Company Type, Viral Vector CDMO Area Served and Its Competitors
Table 129. VIVEBiotech Viral Vector CDMO Product Offered
Table 130. VIVEBiotech Main Business
Table 131. VIVEBiotech Viral Vector CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 132. VIVEBiotech Latest Developments
Table 133. Miltenyi Bioindustry Details, Company Type, Viral Vector CDMO Area Served and Its Competitors
Table 134. Miltenyi Bioindustry Viral Vector CDMO Product Offered
Table 135. Miltenyi Bioindustry Main Business
Table 136. Miltenyi Bioindustry Viral Vector CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 137. Miltenyi Bioindustry Latest Developments
Table 138. Genezen Details, Company Type, Viral Vector CDMO Area Served and Its Competitors
Table 139. Genezen Viral Vector CDMO Product Offered
Table 140. Genezen Main Business
Table 141. Genezen Viral Vector CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 142. Genezen Latest Developments
Table 143. Miltenyi Biotec Details, Company Type, Viral Vector CDMO Area Served and Its Competitors
Table 144. Miltenyi Biotec Viral Vector CDMO Product Offered
Table 145. Miltenyi Biotec Main Business
Table 146. Miltenyi Biotec Viral Vector CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 147. Miltenyi Biotec Latest Developments
Table 148. Exthera Details, Company Type, Viral Vector CDMO Area Served and Its Competitors
Table 149. Exthera Viral Vector CDMO Product Offered
Table 150. Exthera Main Business
Table 151. Exthera Viral Vector CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 152. Exthera Latest Developments
Table 153. Catalent Details, Company Type, Viral Vector CDMO Area Served and Its Competitors
Table 154. Catalent Viral Vector CDMO Product Offered
Table 155. Catalent Viral Vector CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 156. Catalent Main Business
Table 157. Catalent Latest Developments
List of Figures
List of Figures
Figure 1. Viral Vector CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Viral Vector CDMO Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Viral Vector CDMO Market Size Market Share by Type in 2021
Figure 7. Viral Vector CDMO in Biopharmaceutical Company
Figure 8. Global Viral Vector CDMO Market: Biopharmaceutical Company (2017-2022) & ($ Millions)
Figure 9. Viral Vector CDMO in Academic Scientific Research Institution
Figure 10. Global Viral Vector CDMO Market: Academic Scientific Research Institution (2017-2022) & ($ Millions)
Figure 11. Global Viral Vector CDMO Market Size Market Share by Application in 2021
Figure 12. Global Viral Vector CDMO Revenue Market Share by Player in 2021
Figure 13. Global Viral Vector CDMO Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Viral Vector CDMO Market Size 2017-2022 ($ Millions)
Figure 15. APAC Viral Vector CDMO Market Size 2017-2022 ($ Millions)
Figure 16. Europe Viral Vector CDMO Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Viral Vector CDMO Market Size 2017-2022 ($ Millions)
Figure 18. Americas Viral Vector CDMO Value Market Share by Country in 2021
Figure 19. Americas Viral Vector CDMO Consumption Market Share by Type in 2021
Figure 20. Americas Viral Vector CDMO Market Size Market Share by Application in 2021
Figure 21. United States Viral Vector CDMO Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Viral Vector CDMO Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Viral Vector CDMO Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Viral Vector CDMO Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Viral Vector CDMO Market Size Market Share by Region in 2021
Figure 26. APAC Viral Vector CDMO Market Size Market Share by Application in 2021
Figure 27. China Viral Vector CDMO Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Viral Vector CDMO Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Viral Vector CDMO Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Viral Vector CDMO Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Viral Vector CDMO Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Viral Vector CDMO Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Viral Vector CDMO Market Size Market Share by Country in 2021
Figure 34. Europe Viral Vector CDMO Market Size Market Share by Type in 2021
Figure 35. Europe Viral Vector CDMO Market Size Market Share by Application in 2021
Figure 36. Germany Viral Vector CDMO Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Viral Vector CDMO Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Viral Vector CDMO Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Viral Vector CDMO Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Viral Vector CDMO Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Viral Vector CDMO Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Viral Vector CDMO Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Viral Vector CDMO Market Size Market Share by Application in 2021
Figure 44. Egypt Viral Vector CDMO Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Viral Vector CDMO Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Viral Vector CDMO Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Viral Vector CDMO Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Viral Vector CDMO Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 50. APAC Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 51. Europe Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 53. United States Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 54. Canada Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 57. China Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 58. Japan Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 59. Korea Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 61. India Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 62. Australia Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 63. Germany Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 64. France Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 65. UK Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 66. Italy Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 67. Russia Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 68. Spain Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 71. Israel Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Viral Vector CDMO Market Size 2023-2028 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets